These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25322194)

  • 1. Radiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography.
    Sirianni RW; Zheng MQ; Patel TR; Shafbauer T; Zhou J; Saltzman WM; Carson RE; Huang Y
    Bioconjug Chem; 2014 Dec; 25(12):2157-65. PubMed ID: 25322194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
    Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM
    Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.
    Park J; Mattessich T; Jay SM; Agawu A; Saltzman WM; Fahmy TM
    J Control Release; 2011 Nov; 156(1):109-15. PubMed ID: 21723893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
    Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
    Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
    Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
    Chen HA; Ma YH; Hsu TY; Chen JP
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
    Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
    J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers.
    Chen W; Hu S
    Int J Nanomedicine; 2011; 6():1535-41. PubMed ID: 21845043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactic-co-glycolic) Acid/Solutol HS15-Based Nanoparticles for Docetaxel Delivery.
    Cho HJ; Park JH; Kim DD; Yoon IS
    J Nanosci Nanotechnol; 2016 Feb; 16(2):1433-6. PubMed ID: 27433600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
    Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM
    Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.
    Cu Y; Saltzman WM
    Mol Pharm; 2009; 6(1):173-81. PubMed ID: 19053536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles.
    Shen H; Hu X; Szymusiak M; Wang ZJ; Liu Y
    Mol Pharm; 2013 Dec; 10(12):4546-51. PubMed ID: 24195658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized avidin nucleic acid nanoassemblies by a tailored PEGylation strategy and their application as molecular amplifiers in detection.
    Pignatto M; Realdon N; Morpurgo M
    Bioconjug Chem; 2010 Jul; 21(7):1254-63. PubMed ID: 20527874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
    Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
    J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.
    Li J; Feng L; Fan L; Zha Y; Guo L; Zhang Q; Chen J; Pang Z; Wang Y; Jiang X; Yang VC; Wen L
    Biomaterials; 2011 Jul; 32(21):4943-50. PubMed ID: 21470674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles Based on Novel Carbohydrate-Functionalized Polymers.
    Raposo CD; Conceição CA; Barros MT
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
    S S; S M; P S L S; S S; S B; V P
    Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.